Corporate financial fragility, R&D investment, and corporate green innovation: Evidence from China

被引:9
|
作者
Zhang, Zuomin [1 ,2 ]
Wu, Yingjue [1 ]
Wang, Honglei [3 ]
机构
[1] Hainan Univ, Sch Int Business, Haikou, Peoples R China
[2] Yunnan Univ, Sch Econ, Kunming, Peoples R China
[3] Yunnan Univ Finance & Econ, Sch Econ, Kunming, Peoples R China
基金
中国国家自然科学基金;
关键词
Corporate financial fragility; Green innovation; R & d investment; Government subsidy; PERFORMANCE; DISTRESS; SYSTEM; IMPACT; ENERGY;
D O I
10.1016/j.frl.2024.105190
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
We investigate the impact of corporate financial fragility on corporate green innovation and its underlying mechanisms. Using a sample of Chinese A-share listed firms from 2013 to 2019, we find that financially fragile firms are more likely to reduce green innovation than general innovation. Mechanism analysis indicates that corporate financial fragility diminishes firms' R&D investments, restraining their green innovation activities. Furthermore, we observe that overall subsidies increase R&D expenditure but that this effect is similar for firms that are more financially fragile. However, subsidies have a less intense effect on increasing green patents for financially fragile firms than for other firms; for firms that receive more subsidies, the effect of R&D on green patents is slightly more substantial. This study elucidates the mechanism of corporate financial status on corporate green innovation and compares the different impacts of government subsidies on green innovation between financially fragile firms and general firms.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Spillover Effects of Preventive Regulation and Corporate R&D Investment Catering: Evidence from China
    Yu, Yan
    Lee, Yi-Tsung
    EMERGING MARKETS FINANCE AND TRADE, 2023, 59 (11) : 3391 - 3401
  • [22] Democracy and corporate R&D investment
    Tran, Quoc Trung
    BORSA ISTANBUL REVIEW, 2022, 22 (03) : 465 - 476
  • [23] Financial misconduct and corporate innovation: evidence from China
    Mbanyele, William
    Wang, Fengrong
    CHINESE MANAGEMENT STUDIES, 2024, 18 (04) : 1021 - 1046
  • [24] Executive pharmaceutical background, R&D investment and corporate innovation performance
    Zhang, Linrong
    Li, Shiyu
    Wu, Mengyun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (11): : 6576 - 6586
  • [25] Green R & D investment, ESG reporting, and corporate green innovation performance
    Rauf, Fawad
    Wanqiu, Wang
    Naveed, Khwaja
    Zhang, Yanqiu
    PLOS ONE, 2024, 19 (03):
  • [26] How does multidimensional R&D investment affect green innovation? Evidence from China
    Shi, Yang
    Yang, Can
    FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [27] Does anti-corruption campaign promote corporate R&D investment? Evidence from China
    Gan Weiyu
    Xu Xixiong
    FINANCE RESEARCH LETTERS, 2019, 30 : 292 - 296
  • [28] Corporate finance policies, subsidies and R&D: Evidence from China
    Huang, Wei
    Sattar, Mahnoor
    INTERNATIONAL JOURNAL OF FINANCE & ECONOMICS, 2021, 26 (03) : 3875 - 3891
  • [29] Property rights protection and corporate R&D: Evidence from China
    Lin, Chen
    Lin, Ping
    Song, Frank
    JOURNAL OF DEVELOPMENT ECONOMICS, 2010, 93 (01) : 49 - 62
  • [30] Does the presentation reform of R&D expenses in China ease financial constraints in corporate innovation?
    Li, Zhou
    Liu, Bin
    Liu, Yuanyuan
    JOURNAL OF INTERNATIONAL FINANCIAL MANAGEMENT & ACCOUNTING, 2023, 34 (03) : 826 - 851